Stockscreener 앱 받기
0.845
2.87%
-0.025
Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스
Aug PreEarnings: Is CASI Pharmaceuticals Inc stock a contrarian buyJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - moha.gov.vn
CASI Pharmaceuticals, Inc. announced that it expects to receive $20 million in funding from Emerging Technology Partners, LLC - marketscreener.com
CASI Pharmaceuticals secures $20 million funding for transplant rejection study - Investing.com
CASI Pharmaceuticals Secures $20 Million for Renal AMR Study - TipRanks
CASI Pharmaceuticals secures $20 million funding for transplant rejection study By Investing.com - Investing.com South Africa
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing - The Joplin Globe
CASI Pharmaceuticals (NASDAQ: CASI) plans $20 million notes to fund China AMR trial - Stock Titan
CASI Pharmaceuticals reports positive phase 1 data for ITP treatment - Investing.com
CASI Pharmaceuticals reports positive phase 1 data for ITP treatment By Investing.com - Investing.com Australia
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting - ACCESS Newswire
Casi Pharmaceuticals announces CID-103 immune thrombocytopenia study results - MSN
How sustainable is CASI Pharmaceuticals Inc. stock dividend payoutEarnings Trend Report & Verified Technical Trade Signals - Newser
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES - GuruFocus
CASI Pharmaceuticals, Inc. (CASI) 6.93% in After-hours: What’s Driving the Move? - Stocks Telegraph
Hedge Fund Moves: What margin trends mean for CASI Pharmaceuticals Inc. stockWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - moha.gov.vn
CASI Pharmaceuticals Announces Changes in Board Governance - Investing News Network
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results - Investing News Network
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ - Investing News Network
Lacklustre Performance Is Driving CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) 27% Price Drop - simplywall.st
CASI Pharmaceuticals Inc. (CASI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Casi Pharmaceuticals appoints James Huang as non-executive chairman - MSN
CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman - The Globe and Mail
How resilient is CASI Pharmaceuticals Inc. stock in market downturns2025 Key Lessons & Long-Term Capital Growth Strategies - newser.com
How CASI Pharmaceuticals Inc. stock performs in weak economyGap Up & Daily Growth Stock Tips - newser.com
How to read the order book for CASI Pharmaceuticals Inc.2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
Is CASI Pharmaceuticals Inc. stock gaining market shareJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Is CASI Pharmaceuticals Inc. stock a top momentum playMarket Performance Summary & Weekly High Potential Alerts - newser.com
[6-K] CASI Pharmaceuticals, Inc. Current Report (Foreign Issuer) | CASI SEC FilingForm 6-K - Stock Titan
CASI Pharmaceuticals (NASDAQ: CASI) appoints James Huang Non-Executive Chairman - Stock Titan
CASI Pharmaceuticals Names James Huang Non-Executive Chairman of Board - marketscreener.com
What MACD and RSI say about CASI Pharmaceuticals Inc.2025 Macro Impact & Fast Entry Momentum Alerts - newser.com
Smart tools for monitoring CASI Pharmaceuticals Inc.’s price actionTrade Analysis Summary & Safe Swing Trade Setups - newser.com
Is CASI Pharmaceuticals Inc. stock attractive for retirement portfoliosTrade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Can CASI Pharmaceuticals Inc. stock resist sector downturnsBuy Signal & Expert Approved Momentum Trade Ideas - newser.com
Will CASI Pharmaceuticals Inc. stock attract more institutional investorsChart Signals & Capital Protection Trade Alerts - newser.com
CASI Pharmaceuticals Stumbles On Revenue Drop And Nasdaq Challenge - Finimize
CASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal - MSN
0.42%
0.32%
자본화:
|
볼륨(24시간):